6 October 2022
FII & DII DATA
FII Net BUY - 279.01cr
DII Net SELL - 43.92cr
FII & DII DATA
FII Net BUY - 279.01cr
DII Net SELL - 43.92cr
During the quarter ended September FY23, inflation was at peak levels which impacted gross margins, and operating margin in Q2FY23 is expected to be lower by around 150-200 basis points versus Q2FY22.
07/10/22
Stocks In Focus , Share Market News
Quess Crop
Quess Corp to divest 53% stake in subsidiary Simpliance Technologies. The company has entered into definitive agreements to divest its 53% stake in subsidiary Simpliance Technologies to Aparajitha Corporate Services, an HR compliance services company. The deal is valued at an enterprise value of Rs 120 crore on a cash and debt-free basis
Indian Hume Pipe Company
Indian Hume Pipe Company bags order worth Rs 194 crore under Jal Jeevan Mission Project in Maharashtra. The company has received Letter of Acceptance for the work of Rs 194.03 crore from Maharashtra Jeevan Pradhikaran Division, Buldhana, Maharashtra, under Jal Jeevan Mission Project for Jalgaon Jamod 150 Villages Regional Rural Water Supply Scheme. The project is to be completed within 24 months with a trial run for 12 months after completion of project.
Themis Medicare
Themis Medicare partners with NFL Biosciences for development of drug for tobacco cessation in India. The company has entered into a partnership with NFL Biosciences to develop NFL-101, the drug candidate for smoking cessation, for the Indian market. Themis submitted an IND (investigational new drug) application for a Phase II-III clinical trial to the Central Drugs Standard Control Organization (CDSCO),
the National Regulatory Authority of India (NRA)
07/10/22
Stocks In Focus , Share Market News
Quess Crop
Quess Corp to divest 53% stake in subsidiary Simpliance Technologies. The company has entered into definitive agreements to divest its 53% stake in subsidiary Simpliance Technologies to Aparajitha Corporate Services, an HR compliance services company. The deal is valued at an enterprise value of Rs 120 crore on a cash and debt-free basis
Indian Hume Pipe Company
Indian Hume Pipe Company bags order worth Rs 194 crore under Jal Jeevan Mission Project in Maharashtra. The company has received Letter of Acceptance for the work of Rs 194.03 crore from Maharashtra Jeevan Pradhikaran Division, Buldhana, Maharashtra, under Jal Jeevan Mission Project for Jalgaon Jamod 150 Villages Regional Rural Water Supply Scheme. The project is to be completed within 24 months with a trial run for 12 months after completion of project.
Themis Medicare
Themis Medicare partners with NFL Biosciences for development of drug for tobacco cessation in India. The company has entered into a partnership with NFL Biosciences to develop NFL-101, the drug candidate for smoking cessation, for the Indian market. Themis submitted an IND (investigational new drug) application for a Phase II-III clinical trial to the Central Drugs Standard Control Organization (CDSCO),
the National Regulatory Authority of India (NRA)
0 Comments